Avinger, Inc. (NASDAQ:AVGR) Q2 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Avinger Second Quarter 2023 Results Call. At this time, all participants are in a listen-only mode.
Source: insidermonkey.com
Rutherford Class News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Rutherford Class. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Rutherford Class Today - Breaking & Trending Today
Avinger, Inc.: Leading Data on the Treatment of In-Stent Restenosis with Pantheris Presented at Charing Cross International Symposium
REDWOOD CITY, CA / ACCESSWIRE / April 28, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for
Source: finanznachrichten.de
One-Year BIOPACT Randomized Controlled Trial (RCT) Results Demonstrate Excellent Results for Low-Profile Passeo-18 Lux DCB
Head-to-Head Non-Inferiority Study Shows Equivalent Safety and Efficacy of Passeo-18 Lux DCB to In.Pact Admiral DCB in Treatment of Femoropopliteal LesionsÂ
Source: dicardiology.com
Avinger, Inc.: Ground-Breaking Clinical Data from INSIGHT Trial Presented at VIVA
Study Outcomes Demonstrate Safety and Efficacy of Pantheris for Treatment of In-Stent RestenosisREDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical
Source: finanznachrichten.de